Analyst Ratings for Ultragenyx Pharma (RARE)

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $142.27 (+51.8%) * Over Last 12-Mos
Rating Score: 5.7 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/4/2021 Baird Joel Beatty New Coverage Neutral
(N/A)
109.00
(N/A)
97.70
(93.72)
-4.07% Details
5/6/2021 Citi Yigal Nochomovitz Upgrade Buy
(Neutral)
151.00
(160.00)
101.85
(93.72)
-7.98% Details
Like RARE Ratings? Also take a look at MREO, SLDB, ECHO, AMSC

RARE Ratings News